Patent details
EP1811986
Title:
GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS
Basic Information
- Publication number:
- EP1811986
- PCT Application Number:
- PCT/US/2005/040127
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP058262007
- PCT Publication Number:
- WO/2006/050514
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS
- French Title of Invention:
- FORMES POSOLOGIQUES ORALES A LIBERATION PROLONGEE D'UN PROMEDICAMENT DE LA GABAPENTINE
- German Title of Invention:
- ORALE DARREICHUNGSFORMEN VON GABAPENTIN-PRODRUG MIT VERZÖGERTER FREISETZUNG
- SPC Number:
-
Dates
- Filing date:
- 03/11/2005
- Grant date:
- 26/03/2014
- EP Publication Date:
- 26/03/2014
- PCT Publication Date:
- 11/05/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/08/2007
- EP B1 Publication Date:
- 26/03/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 03/11/2014
- Expiration date:
- 03/11/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/11/2005
-
-
- Name:
- XenoPort Inc.
- Address:
- 3410 Central Expressway, Santa Clara, CA 95051, United States (US)
Inventor
1
- Name:
- LEUNG Manshiu
- Address:
- United States (US)
2
- Name:
- CUNDY Kenneth, C.
- Address:
- United States (US)
3
- Name:
- STACH Paul, E.
- Address:
- United States (US)
4
- Name:
- SASTRY Srikonda
- Address:
- United States (US)
5
- Name:
- KADRI Balaji, V.
- Address:
- United States (US)
Priority
- Priority Number:
- 625737 P
- Priority Date:
- 04/11/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 31/225;
| Filing date |
Document type |
Number of pages |